Japan, Sept. 9 -- REGENERON PHARMACEUTICALS INC has got intellectual property rights for 'COMPOSITIONS AND METHODS FOR MAKING ANTIBODIES BASED ON USE OF EXPRESSION-ENHANCING LOCI.' Other related details are as follows:
Application Number: JP,2021-114374
Category (FI): C12N15/11@Z,C12N5/10,C12N15/13,C12N5/071,C12N15/63@Z,C12P21/08
Stage: Grant (IP right granted following substantive examination.)
Filing Date: July 9, 2021
Publication Date: Oct. 14, 2021
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
